Revascularization of AMI Patients Persists Despite No Demonstrated Benefit
He said the U.S. "must heed the call to professional responsibility aimed at the elimination of tests and treatments that do not result in any benefit for our patients, and for which the net effects will be added costs, waste, and possible harm."
Hochman said that for now, physicians should become more diligent about doing what's in the best interests of patients. "It's incumbent on them to take it upon themselves to stop doing procedures with no demonstrated benefit so that we can bring down healthcare costs before some expert body, like a health insurance company says we're not going to reimburse for it.
- Ratcheting Up Patient Experience Has a Downside
- 'Mega Boards' Could be Rural Healthcare Disruptor
- Narrow Networks Enjoying a Resurgence
- Physicians Trained in High-Cost Regions Spend More
- HL20: Anne Wojcicki—Unlocking Consumer Access to Genetics
- HL20: Lee Aase—Who's Behind @MayoClinic
- Christmas Tree Syndrome Season Underway
- Population Health Starts with Ending Hunger
- HL20: Tom X. Lee, MD—Reinventing Primary Care
- HL20: José Ramón Fernández-Peña, MD, MPA—A Welcoming Approach